Advertisement

Topics

Clinical Trials About "Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma" RSS

19:28 EDT 24th March 2019 | BioPortfolio

We list hundreds of Clinical Trials about "Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma" on BioPortfolio

We have published hundreds of Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma news stories on BioPortfolio along with dozens of Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Clinical Trials and PubMed Articles about Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Companies in our database. You can also find out about relevant Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Drugs and Medications on this site too.

Showing "Antineoplaston Therapy Treating Patients With Advanced Mesothelioma" Clinical Trials 1–25 of 27,000+

Extremely Relevant

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with advanced mesothelioma.


Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have glioblastoma multiforme.

Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with anaplastic astrocytoma that has not responded to previous treatment.


Antineoplaston Therapy in Treating Patients With Stage IV Melanoma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with progressive or recurrent stage IV melanoma.

Antineoplaston Therapy in Treating Patients With Stomach Cancer

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have stomach cancer.

Antineoplaston Therapy in Treating Patients With Brain Tumors

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with brain tumors.

Antineoplaston Therapy in Treating Patients With Multiple Myeloma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with recurrent or progressive multiple myeloma after treatment.

Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have soft tissue sarcoma.

Antineoplaston Therapy in Treating Patients With Brain Stem Glioma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with brain stem glioma.

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have recurrent or refractory Waldenstrom's macroglobulinemia.

Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with residual or recurrent anaplastic astrocytoma.

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

RATIONALE: Palliative therapy may help patients with advanced cancer live more comfortably. It is not yet known if palliative therapy is more effective with or without chemotherapy in treating patients who have malignant mesothelioma. PURPOSE: Randomized phase II trial to compare the effectiveness of palliative therapy with or without different chemotherapy regimens in treating patients who have malignant mesothelioma.

Antineoplaston Therapy in Treating Women With Advanced Breast Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating women with stage IV breast cancer that has not responded to standard therapy.

Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with stage IV adrenal gland cancer.

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have metastatic, recurrent, or refractory neuroblastoma.

Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with stage IV pancreatic cancer.

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have stage IV kidney cancer.

Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating children with low-grade astrocytoma.

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have stage IV cancer of the cervix and/or vulva.

Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have cancer of the small intestine.

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have refractory stage IV prostate cancer.

Antineoplaston Therapy in Treating Children With Brain Tumors

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating children with brain tumors.

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with cancer of unknown primary origin.

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating patients who have stage III or stage IV ovarian cancer


More From BioPortfolio on "Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma"

Advertisement
Quick Search
Advertisement
Advertisement